Annual report pursuant to Section 13 and 15(d)

Stock-Based Compensation - Schedule of Stock Option Activity (Details)

v3.22.1
Stock-Based Compensation - Schedule of Stock Option Activity (Details) - USD ($)
$ / shares in Units, $ in Thousands
 3 Months Ended 12 Months Ended
Sep. 30, 2021
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Shares        
Beginning balance (in shares)   1,208,740 1,465,450  
Granted (in shares) 50,000 0 0  
Exercised (in shares)   (260,451) (185,234)  
Canceled/expired (in shares)   (22,822) (71,476)  
Ending balance (in shares)   925,467 1,208,740 1,465,450
Options exercisable (in shares)   904,259,000    
Weighted Average Grant Date Fair Value        
Beginning balance (in dollars per share)   $ 0.80 $ 0.80  
Granted (in dollars per share) $ 1.08 0 0  
Exercised (in dollars per share)   0.69 1.06  
Cancelled/expired (in dollars per share)   2.01 1.77  
Ending balance (in dollars per share)   0.80 $ 0.80 $ 0.80
Options exercisable (in dollars per share)   $ 0.79    
Weighted Average Remaining Contractual Term (years)        
Outstanding (in years)   5 years 7 months 2 days 6 years 2 months 8 days 6 years 10 months 9 days
Weighted Average Remaining Contractual Term (years), Exercisable   5 years 6 months 29 days    
Aggregate Intrinsic Value        
Outstanding   $ 1,692 $ 700 $ 771
Options exercisable   $ 1,668